Cleveland-Cliffs: Barclays raises target price to $11 from $10
CLF•Barclays raised its target price for Cleveland-Cliffs to $11 from $10.
Related News
United Therapeutics gets FDA clearance for treprostinil SMI trial in PH-COPD
UTHR•
Douglas Emmett, Inc.: BMO cuts target price to $11 from $13
DEI•
SpaceX spectrum deal reinforces need for terrestrial towers, Gravis says
SPCX•
SL Green Realty Corp: BMO cuts target price to $54 from $60
SLG•
Jefferies presents record LTM investment banking net revenues of $4.7 billion
JEF•